As of 2026-03-22, the Relative Valuation of ImmunoGen Inc (IMGN) is (5.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on Relative Valuation is -118.2%.
The range of the Relative Valuation is (5.11) - (6.07) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 25.3x | 22.2x |
| Forward P/E multiples | 19.4x - 23.1x | 21.1x |
| Fair Price | (5.11) - (6.07) | (5.69) |
| Upside | -116.4% - -119.4% | -118.2% |
| Date | P/E |